Myths vs facts: AMH and Fruchtbarkeit

AMH (Anti-Müllerian Hormone) is often marketed as a 'fertility test', but the reality is more nuanced. Fact: AMH correlates with the number of remaining eggs (ovarian reserve), but it does not predict egg quality or the likelihood of natural conception. Myth: A low AMH automatically means infertility. In fact, women with low AMH can conceive naturally, while a high AMH (e.g., in PCOS) does not guarantee pregnancy. AMH is a useful marker for predicting response to IVF, but not a standalone fertility predictor. Evidence comes from large cohort studies (human-moderate). Important: AMH levels fluctuate with age, cycle phase, and hormonal factors; a single test is insufficient for a reliable prognosis. Moreover, commercial home tests often lack standardization. The American College of Obstetricians and Gynecologists (ACOG) and the European Society of Human Reproduction and Embryology (ESHRE) recommend AMH only in the context of fertility treatment, not as a general fertility screening. Bottom line: AMH is an indicator, not a destiny.